A tool for decision-making in kidney transplant candidates with poor prognosis to receive deceased donor transplantation in the United States

• Published in: Kidney international Vol. 102; no. 3; pp. 640 - 651
• Main Authors: Schold, Jesse D., Huml, Anne M., Poggio, Emilio D., Reese, Peter P., Mohan, Sumit
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01.09.2022
• Subjects: diabetes; kidney transplantation; patient survival; shared decision-making; transplantation; wait-listed candidates; patient survival; diabetes; kidney transplantation; shared decision-making; transplantation; wait-listed candidates
• ISSN: 0085-2538; 1523-1755
• DOI: 10.1016/j.kint.2022.05.025

The primary outcomes for kidney transplant candidates are receipt of deceased or living donor transplant, death or removal from the waiting list. Here, we conducted a retrospective analysis of national Scientific Registry of Transplant Recipients data to evaluate outcomes for 208,717 adult kidney transplant candidates following the 2014 Kidney Allocation System in the United States. Competing risks models were utilized to evaluate Time to Equivalent Risk (TiTER) of deceased donor transplantation (DDTX) and death versus waitlist removal. We also evaluated TiTER based on kidney donor profile index (KDPI) and donor age. For all groups, the cumulative incidence of DDTX was initially higher from time of listing than death or waitlist removal. However, following accrued time on the waiting list, the cumulative incidence of death or waitlist removal exceeded DDTX for certain patient groups, particularly older, diabetic, blood type B and O and shorter pre-listing dialysis time. TiTER for all candidates aged 65-69 averaged 41 months and for 70 and older patients 28 months. Overall, 39.6% of candidates were in risk groups with TiTER under 72 months and 18.5% in groups with TiTER under 24 months. Particularly for older candidates, TiTER for kidneys was substantially shorter for younger donors or lower KDPI. Thus, our findings reveal that a large proportion of wait-listed patients in the United States have poor prognoses to ever undergo DDTX and our data may improve shared decision-making for candidates at time of waitlist placement. Hence, for specific patient groups, TiTER may be a useful tool to disseminate and quantify benefits of accepting relatively high risk donor organs. [Display omitted]